[1]
Gomes, C.O. et al. 2025. APPLICABILITY OF GLP-1 RECEPTOR AGONISTS IN REFRACTORY IMMUNE-MEDIATED DERMATOLOGICAL DISEASES: THERAPEUTIC PERSPECTIVES IN PSORIASIS. Revista Ibero-Americana de Humanidades, Ciências e Educação. 11, 12 (Dec. 2025), 2493–2504. DOI:https://doi.org/10.51891/rease.v11i12.23068.